185 related articles for article (PubMed ID: 12538788)
21. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
[TBL] [Abstract][Full Text] [Related]
23. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
24. Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2.
Mano Y; Usui T; Kamimura H
Biopharm Drug Dispos; 2007 Jan; 28(1):13-8. PubMed ID: 17061295
[TBL] [Abstract][Full Text] [Related]
25. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
[TBL] [Abstract][Full Text] [Related]
26. Differential roles of ubiquitination in the degradation mechanism of cell surface-resident bile salt export pump and multidrug resistance-associated protein 2.
Aida K; Hayashi H; Inamura K; Mizuno T; Sugiyama Y
Mol Pharmacol; 2014 Mar; 85(3):482-91. PubMed ID: 24378332
[TBL] [Abstract][Full Text] [Related]
27. The bile salt export pump.
Stieger B; Meier Y; Meier PJ
Pflugers Arch; 2007 Feb; 453(5):611-20. PubMed ID: 17051391
[TBL] [Abstract][Full Text] [Related]
28. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
[TBL] [Abstract][Full Text] [Related]
29. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
30. Regulation of biliary drug efflux pump expression by hormones and xenobiotics.
Fardel O; Payen L; Courtois A; Vernhet L; Lecureur V
Toxicology; 2001 Oct; 167(1):37-46. PubMed ID: 11557128
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of canalicular transporter endocytosis in the cholestatic rat liver.
Miszczuk GS; Barosso IR; Larocca MC; Marrone J; Marinelli RA; Boaglio AC; Sánchez Pozzi EJ; Roma MG; Crocenzi FA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1072-1085. PubMed ID: 29355600
[TBL] [Abstract][Full Text] [Related]
32. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
[TBL] [Abstract][Full Text] [Related]
33. Regulation of bile salt export pump mRNA levels by dexamethasone and osmolarity in cultured rat hepatocytes.
Warskulat U; Kubitz R; Wettstein M; Stieger B; Meier PJ; Häussinger D
Biol Chem; 1999 Nov; 380(11):1273-9. PubMed ID: 10614819
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver.
Vos TA; Hooiveld GJ; Koning H; Childs S; Meijer DK; Moshage H; Jansen PL; Müller M
Hepatology; 1998 Dec; 28(6):1637-44. PubMed ID: 9828229
[TBL] [Abstract][Full Text] [Related]
35. Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17β-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C.
Boaglio AC; Zucchetti AE; Sánchez Pozzi EJ; Pellegrino JM; Ochoa JE; Mottino AD; Vore M; Crocenzi FA; Roma MG
Hepatology; 2010 Oct; 52(4):1465-76. PubMed ID: 20815017
[TBL] [Abstract][Full Text] [Related]
36. Bile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of Troglitazone.
Cheng Y; Chen S; Freeden C; Chen W; Zhang Y; Abraham P; Nelson DM; Humphreys WG; Gan J; Lai Y
J Pharmacol Exp Ther; 2017 Sep; 362(3):385-394. PubMed ID: 28645914
[TBL] [Abstract][Full Text] [Related]
37. Experimental LPS-induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: a quantitative colocalization study.
Zinchuk V; Zinchuk O; Okada T
Microsc Res Tech; 2005 Jun; 67(2):65-70. PubMed ID: 16037978
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of BSEP and MRP2 by Calculus Bovis administration in 17α-ethynylestradiol-induced cholestasis: Involvement of PI3K/Akt signaling pathway.
Wu T; Zhang Q; Li J; Chen H; Wu J; Song H
J Ethnopharmacol; 2016 Aug; 190():22-32. PubMed ID: 27237619
[TBL] [Abstract][Full Text] [Related]
39. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Funk C; Ponelle C; Scheuermann G; Pantze M
Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms by which cAMP increases bile acid secretion in rat liver and canalicular membrane vesicles.
Misra S; Varticovski L; Arias IM
Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G316-24. PubMed ID: 12702492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
